Tipo de artículo
Condición
Encuadernación
Más atributos
Ubicación del vendedor
Valoración de los vendedores
Publicado por Wiley, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: Wonder Book, Frederick, MD, Estados Unidos de America
Libro
Condición: As New. Like New condition. A near perfect copy that may have very minor cosmetic defects.
Publicado por John Wiley and Sons, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: INDOO, Avenel, NJ, Estados Unidos de America
Libro
Condición: New. Brand New.
Publicado por John Wiley & Sons Inc, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: New.
Publicado por John Wiley & Sons Inc, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Libro
Condición: As New. Unread book in perfect condition.
Publicado por John Wiley & Sons Inc, New York, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: Grand Eagle Retail, Wilmington, DE, Estados Unidos de America
Libro Original o primera edición
Hardcover. Condición: new. Hardcover. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these newer agents have been scattered in various journals and in US and European patents. This timely volume deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. Compounds are collected in chapters based on the mechanism of action rather than on their chemical structures. Each individual chapter is preceded by a brief description of that mechanism and includes detailed flow charts of the preparation of those compounds accompanied by discussions of the organic chemistry involved in each step. The first half of this volume is dedicated to the syntheses of established chemotherapy drugs. Kinase inhibitors occupy the following chapters with the largest single chapter dealing with the fifty compounds that inhibit tyrosine kinase. This class stands out since over twenty compounds in this group have been approved for treating patients; a rare track record compared to any other class of therapeutic agents. Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations. The book is accessible to advanced undergraduates as well as graduates and researchers as well as those with a thorough grasp of organic chemistry. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Publicado por Wiley, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Libro
Condición: As New. Unread book in perfect condition.
Publicado por John Wiley & Sons Inc, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Libro
Condición: New.
Publicado por John Wiley & Sons, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: moluna, Greven, Alemania
Libro
Gebunden. Condición: New. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these.
Publicado por John Wiley and Sons Ltd, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Libro Original o primera edición
Condición: New. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Num Pages: 232 pages. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 176 x 252 x 20. Weight in Grams: 506. . 2015. 1st Edition. Hardcover. . . . .
Publicado por John Wiley & Sons Inc, New York, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: CitiRetail, Stevenage, Reino Unido
Libro Original o primera edición
Hardcover. Condición: new. Hardcover. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these newer agents have been scattered in various journals and in US and European patents. This timely volume deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. Compounds are collected in chapters based on the mechanism of action rather than on their chemical structures. Each individual chapter is preceded by a brief description of that mechanism and includes detailed flow charts of the preparation of those compounds accompanied by discussions of the organic chemistry involved in each step. The first half of this volume is dedicated to the syntheses of established chemotherapy drugs. Kinase inhibitors occupy the following chapters with the largest single chapter dealing with the fifty compounds that inhibit tyrosine kinase. This class stands out since over twenty compounds in this group have been approved for treating patients; a rare track record compared to any other class of therapeutic agents. Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations. The book is accessible to advanced undergraduates as well as graduates and researchers as well as those with a thorough grasp of organic chemistry. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Publicado por John Wiley and Sons Ltd, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
Libro
Condición: New. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Num Pages: 232 pages. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 176 x 252 x 20. Weight in Grams: 506. . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Publicado por John Wiley & Sons Inc, New York, 2015
ISBN 10: 1118892542ISBN 13: 9781118892541
Librería: AussieBookSeller, Truganina, VIC, Australia
Libro Original o primera edición
Hardcover. Condición: new. Hardcover. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these newer agents have been scattered in various journals and in US and European patents. This timely volume deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. Compounds are collected in chapters based on the mechanism of action rather than on their chemical structures. Each individual chapter is preceded by a brief description of that mechanism and includes detailed flow charts of the preparation of those compounds accompanied by discussions of the organic chemistry involved in each step. The first half of this volume is dedicated to the syntheses of established chemotherapy drugs. Kinase inhibitors occupy the following chapters with the largest single chapter dealing with the fifty compounds that inhibit tyrosine kinase. This class stands out since over twenty compounds in this group have been approved for treating patients; a rare track record compared to any other class of therapeutic agents. Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations. The book is accessible to advanced undergraduates as well as graduates and researchers as well as those with a thorough grasp of organic chemistry. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.